XML 53 R24.htm IDEA: XBRL DOCUMENT
v3.22.4

Merger (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Business Combinations [Abstract] |
Schedule of Sources and Uses of Funds Related to Merger | Summary of Net Proceeds The following table summarizes the net proceeds from the Merger (in thousands):
Panacea cash at bank and cash held in a trust account |  | $ | 144,642 |
Proceeds from PIPE investment and forward purchase agreement |  |  | 501,550 |
Payment of underwriter fees and other offering costs |  |  | (23,913 | )
Payment to Panacea Class A common stockholders who exercised their right to redeem their shares |  |  | (32 | )
Net proceeds |  |  | 622,247 |
Assumed assets and liabilities: |  |  |
Prepaid expenses |  |  | 312 |
Accrued expenses |  |  | (601 | )
Warrant liability |  |  | (15,268 | )
Panacea equity at Effective Time |  | $ | 606,690 |
Summary of Number of Shares of Common Stock Outstanding on Merger | Summary of Shares Issued The following table summarized the number of shares of common stock outstanding immediately following the consummation of the Merger:
|  | Class A Common |  |  | Class B Common |  |  | Total |
Panacea shares outstanding prior to the Merger |  |  | 14,862,500 |  |  |  | 3,593,750 |  |  |  | 18,456,250 |
Less: redemption of Panacea shares prior to the Merger |  |  | (3,350 | ) |  |  |  |  |  | (3,350 | )
Conversion of Panacea shares as a result of the Merger |  |  | 3,593,750 |  |  |  | (3,593,750 | ) |  |  | — |
Common stock of Panacea |  |  | 18,452,900 |  |  |  | — |  |  |  | 18,452,900 |
Shares issued pursuant to the PIPE financing |  |  | 47,655,000 |  |  |  | — |  |  |  | 47,655,000 |
Shares issued pursuant to the Forward Purchase |  |  | 2,500,000 |  |  |  | — |  |  |  | 2,500,000 |
Issuance of shares upon the Merger |  |  | 68,607,900 |  |  |  | — |  |  |  | 68,607,900 |
Conversion of Old Nuvation Redeemable Series A Convertible Preferred Stock |  |  | 68,097,805 |  |  |  | — |  |  |  | 68,097,805 |
Conversion of Old Nuvation Class A common stock |  |  | 23,299,337 |  |  |  | — |  |  |  | 23,299,337 |
Conversion of Old Nuvation Class B common stock |  |  | — |  |  |  | 57,645,013 |  |  |  | 57,645,013 |
Conversion of Founder shares |  |  | 56,645,013 |  |  |  | (56,645,013 | ) |  |  | — |
Total shares of Nuvation Bio outstanding immediately following the Merger |  |  | 216,650,055 |  |  |  | 1,000,000 |  |  |  | 217,650,055 |

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the equity interest issued or issuable in a business acquisition (or series of individually immaterial business acquisitions) planned, initiated, or completed during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration